Navigation Links
Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Date:8/26/2011

low-up period of one year.(11)

The RE-LY trial utilized the established PROBE (prospective, randomized, open-label, blinded endpoint evaluation) clinical trial protocol,(11) which has been used in the previous trials of anticoagulation for stroke prevention in patients with AFib.(11)  A PROBE design may reflect the differences in the management of warfarin and dabigatran in clinical practice.(11)

The primary endpoint of the trial was incidence of stroke (including hemorrhagic) and systemic embolism.(11) Safety endpoints included bleeding events (major and minor), intracerebral hemorrhage, other intracranial hemorrhage, elevations in liver transaminases, bilirubin and hepatic dysfunction and other adverse events.(11)

In the RE-LY trial, all clinical outcomes were adjudicated in a blinded manner to minimize bias in assessment of outcomes for each treatment.(11)

About Pradaxa® (dabigatran etexilate) Capsules

Indications and Usage

PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

IMPORTANT SAFETY INFORMATION ABOUT PRADAXA

CONTRAINDICATIONS

PRADAXA is contraindicated in patients with active pathological bleeding and patients with a known serious hypersensitivity reaction (e.g., anaphylactic reaction or anaphylactic shock) to PRADAXA.

WARNINGS AND PRECAUTIONS

Risk of Bleeding

PRADAXA increases the risk of bleeding and can cause significant and, sometimes, fatal bleeding.

Risk factors for bleeding include:

- Medications that increase the risk of bleeding in general (e.g., anti-platelet agents, heparin, fibrinolytic therapy, and chronic use of NSAIDs).

- Labor and delivery

Promptly evaluate any signs or symptoms of blood loss, such as a drop in hemoglobin and/or hematocrit or hypotension. Discontinue PRADAXA in patients wi
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim and Ashokas Changemakers Launch "Making More Health" Competition
2. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
3. Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity
4. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
5. Positive Phase 2 Results Reported with Boehringer Ingelheims Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
6. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
7. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
8. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
9. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
10. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
11. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/f6rkcf/north_america ... America Portable X Ray Devices Market - Growth, ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... market for Portable X-Ray Devices is expected to ... 2020 X-Ray is a form of ...
(Date:5/27/2015)... , May 26, 2015 Research and Markets( ... Pacific Portable X Ray Devices Market - Growth, Trends And ... The Asia Pacific market ... healthy CAGR from 2014 to 2020 X-Ray is ... the abnormalities in the body, especially bones. The need of ...
(Date:5/27/2015)... 2015 Tout ... horaire. Il nuit sérieusement à la productivité. ... les réunions de mi-journée et vous empêche ... moment dans votre chambre d,hôtel. Même une ... risque de vous empêcher de tenir compagnie ...
Breaking Medicine Technology:North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Asia Pacific Portable X Ray Devices Market 2015 - Trends And Forecasts to 2019 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 2HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 3HumanCharger, l'allié des sportifs d'élite, vous aide à vaincre le décalage horaire deux fois plus vite 4
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 NHL ... in the middle of their series against the Anaheim Ducks with ... the Blackhawks can win tonight at home, this will tie up ... at the Honda Center in Anaheim. , During the regular ... Conference as they won the Pacific Division by 8 points ahead ...
(Date:5/27/2015)... Hills, CA (PRWEB) May 27, 2015 Khanna ... of the art web portal focussed on keratoconus eye ... This relentless progressive disease has its onset in the teenage ... down. The cornea or the front clear part of the ... the pressure in the eye. It results in poor vision ...
(Date:5/27/2015)... 2015 Hundreds of Risperdal lawsuits ... individuals who allegedly suffered gynecomastia (male breast growth) ... the antipsychotic drug continue to move forward in ... Philadelphia Court of Common Pleas. According to court ... trial program, as the third trial involving Risperdal’s ...
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a ... organizations, announced today that SanMar Corporation successfully implemented ... attendance and point tracking processes for over 3,000 ... , Family-owned since 1971, Seattle-based SanMar Corporation ... label, and mill brands. SanMar supplies apparel and ...
Breaking Medicine News(10 mins):Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3
... -- Scientists who first established a link between obesity ... the intestine now are investigating whether the organisms can ... Washington University School of Medicine in St. Louis, led ... malnourished infants living in Malawi and Bangladesh have a ...
... producer says they may have been mixed in during ... The salmonella contamination behind the recall of 1 ... nuts involved in processing at a California plant, according ... Cohen, production manager for Setton International Foods Inc. of ...
... best rankings had similar death rates to those with the ... task just got harder for patients trying to figure out ... study casts doubt on a hospital safety rating conducted by ... ranked in the highest quartile on the safety survey had ...
... 31, 2009 Formerly depressed women show patterns of ... that are distinctly different from the patterns shown by ... Harvard University. The participants reported being completely well and ... has been observed in depressed individuals in other studies. ...
... Successful Collaboration with the U.S. Army- U.S. FDA (Food ... new vaccine against Japanese Encephalitis for adult travelers and ... a result of an excellent collaboration between Intercell and ... U.S.- Supply contract for IXIARO with the U.S. military, ...
... Two Prestigious AwardsWEST ALLIS, Wis., March 31 /PRNewswire/ ... Center has two new awards among ... top 100 hospitals according to Thomson Reuters, and it ... a role model for others.(Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) , ...
Cached Medicine News:Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 2Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 3Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 4Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 2Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 3Health News:Study Casts Doubt on Influential Hospital Safety Survey 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 3Health News:A mother's criticism causes distinctive neural activity among formerly depressed 2Health News:A mother's criticism causes distinctive neural activity among formerly depressed 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 2Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 4Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 5Health News:Aurora West Allis Medical Center Ranked Among the Top 100 U.S. Hospitals 2
... The ALU-1B Halogen Light source ... light source for routine use in ... has a turret which accepts the ... need for separate adapters. The ALU-1B ...
... Ultrasonic Lithotriptor LUS-2 combines two functions ... procedural performance and cost-efficiency. Boasting a ... helps to minimize hand fatigue for ... calculi while simultaneously removing the fragments ...
... MODULARIS Litho from Siemens Medical Solutions is ... management of stone disease. Urodiagnostics, endourology, lithotripsy, ... may all be part of a urologists ... the complete solution that supports the various ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: